MARGARET WILSON: Open Payments
NPI 1538646880 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,182 in 53 payments from 23 companies in 2025. Trend: 2023 $295 · 2024 $410 · 2025 $1,182
Food & beverage: $1,182
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $193 |
| Novo Nordisk Inc | 6 | $156 |
| Lilly USA, LLC | 7 | $133 |
| PFIZER INC. | 5 | $101 |
| Merck Sharp & Dohme LLC | 3 | $88 |
| Sumitomo Pharma America, Inc. | 3 | $65 |
| Exact Sciences Corporation | 2 | $52 |
| SANOFI-AVENTIS U.S. LLC | 2 | $51 |
| Astellas Pharma US Inc | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
Products named: VRAYLAR, Wegovy, MOUNJARO, GEMTESA, CAPVAXIVE, NURTEC ODT, The Cologuard Plus Collection Kit, TZIELD.
Industry payments across MD — which companies pay providers there.
